Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Clinical profile of COVID-19 infection among persons with spinal cord injury: a case series

Abstract

Study design

Retrospective case series.

Objective

To report the clinical features and outcomes of spinal cord injury (SCI) patients with COVID-19 and to see if they are any different from COVID-19 in the general population.

Setting

A tertiary care hospital in North-East India.

Methods

Data of already diagnosed traumatic SCI patients with COVID-19 infection reporting to the COVID-19 management team (from June 2021 to November 2021) were collected. The source of data was hospital records (admitted patients) and home visits and teleconsultation logs (home isolation patients).

Results

There were eight traumatic SCI patients (five admitted, three in home isolation) with COVID-19 infection. Four patients had complete injury with American Spinal Injury Association Impairment Scale (AIS) Grade A, two with AIS Grade C, and one each of Grade B and D respectively. Five patients were cervical level injuries, and others were T10 level and below. Six patients were categorized as mild clinical illness and one each as moderate and severe illness. Cough was the most common symptom which was seen in seven patients. Only two patients needed oxygen therapy. All eight traumatic SCI patients recovered eventually from COVID-19 symptoms and regained their pre-COVID-19 functional status, 1 month after being free from COVID-19 symptoms.

Conclusion

The COVID-19 infection did not result in a worsening of functional ability among SCI people after 1-month post-recovery. It also did not affect the SCI patients in doing activities such as rehabilitation exercises at 6 months follow up.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Data availability

All data generated during the study can be found within the article.

References

  1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020;382:1199–207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. WHO Director-General’s opening remarks at the media briefing on COVID-19. 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020.

  3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Stawicki SP, Jeanmonod R, Miller AC, Paladino L, Gaieski DF, Yaffee AQ, et al. The 2019–2020 novel coronavirus (severe acute respiratory syndrome coronavirus 2) pandemic: a joint American college of academic international medicine-world academic council of emergency medicine multidisciplinary COVID19 working group consensus paper. J Glob Infect Dis. 2020;12:47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection. 2021;49:15–28. https://doi.org/10.1007/s15010-020-01509-1.

    Article  CAS  PubMed  Google Scholar 

  7. Zhang JJ, Dong X, Liu GH, Gao YD. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin Rev Allergy Immunol. 2023;64:90–107. https://doi.org/10.1007/s12016-022-08921-5

    Article  CAS  PubMed  Google Scholar 

  8. Pijls BG, Jolani S, Atherley A, Derckx RT, Dijkstra JIR, Franssen GHL, et al. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ Open. 2021;11:e044640. https://doi.org/10.1136/bmjopen-2020-044640.

    Article  PubMed  Google Scholar 

  9. Cragg JJ, Noonan VK, Krassioukov A, Borisoff J. Cardiovascular disease and spinal cord injury: results from a national population health survey. Neurology. 2013;81:723–8.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Gater DR, Farkas GJ, Berg AS, Castillo C. Prevalence of metabolic syndrome in veterans with spinal cord injury. J Spinal Cord Med. 2019;42:86–93.

    Article  PubMed  Google Scholar 

  11. Cragg JJ, Noonan VK, Dvorak M, Krassioukov A, Mancini GB, Borisoff JF. Spinal cord injury and type 2 diabetes: results from a population health survey. Neurology. 2013;81:1864–8.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Korupolu R, Stampas A, Gibbons C, Jimenez IH, Skelton F, Verduzco-Gutierrez M. COVID-19: screening and triage challenges in people with disability due to spinal cord injury. Spinal Cord Ser Cases. 2020;6:35.

    Article  PubMed  PubMed Central  Google Scholar 

  13. López-Dolado E, Gil-Agudo A. Lessons learned from the coronavirus disease 2019 (Covid-19) outbreak in a monographic center for spinal cord injury. Spinal Cord. 2020;58:517–9.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Riegger T, Conrad S, Liu K, Schluesener HJ, Adibzahdeh M, Schwab JM. Spinal cord injury-induced immune depression syndrome (SCI-IDS). Eur J Neurosci. 2007;25:1743–7.

    Article  PubMed  Google Scholar 

  15. Dicks MA, Clements ND, Gibbons CR, Verduzco-Gutierrez M, Trbovich M. Atypical presentation of Covid-19 in persons with spinal cord injury. Spinal Cord Ser Cases. 2020;6:38.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Marino RJ, Barros T, Biering-Sorensen F. International standards for neurological classification of spinal cord injury. J Spinal Cord Med. 2003;26:S50–S56.

    Article  PubMed  Google Scholar 

  17. Government of India Ministry of Health and Family Welfare. Clinical management protocol for covid-19 (in adults) version 6. Available from URL: https://www.mohfw.gov.in/pdf/updateddetailedclinicalmanagementprotocolforcovid19adultsdated24052021.pdf.

  18. Rodríguez-Cola M, Jiménez-Velasco I, Gutiérrez-Henares F, López-Dolado E, Gambarrutta-Malfatti C, Vargas-BaqueroE, et al. Clinical features of coronavirus disease 2019 (COVID-19) in a cohort of patients with disability due to spinal cord injury. Spinal Cord Ser Cases. 2020;6:39.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Burns SP, Eberhart AC, Sippel JL, Wilson GM, Evans CT. Case fatality with coronavirus disease 2019 (COVID-19) in United States veterans with spinal cord injuries and disorders. Spinal Cord. 2020;58:1040–1.

    Article  PubMed  PubMed Central  Google Scholar 

  20. D’Andrea S, Berardicurti O, Berardicurti A, Felzani G, Francavilla F, Francavilla S, et al. Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study. Spinal Cord Ser Cases. 2020;6:69.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Galea MD, Gelman MA, Galea VP, Raulkar KP, Kornfeld S, Johnson-Kunjukutty S, et al. COVID-19 in spinal cord injury patients at a veterans administration hospital: a case series. J Spinal Cord Med. 2021;1:13.

    Google Scholar 

  22. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–20.

    Article  CAS  PubMed  Google Scholar 

  23. Macera M, De Angelis G, Sagnelli C, Coppola N. Clinical Presentation of COVID-19: case series and review of the literature. Int J Environ Res Public Health. 2020;17:5062. https://doi.org/10.3390/ijerph17145062.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Thevarajan I, Buising KL, Cowie BC. Clinical presentation and management of COVID-19. Med J Aust. 2020;213:134–9. https://doi.org/10.5694/mja2.50698.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Barman A, Roy SS, Sasidharan SK, Sahoo J. Clinical features and prognosis of COVID-19/SARS-CoV-2 infections in persons with spinal cord injury: a review of current literature. Spinal Cord Ser Cases. 2021;7:58.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Zu-Li Z, Yu-Lei H, De-Tao L, Feng-Zeng L. Laboratory findings of COVID-19: a systematic review and meta-analysis. Scand J Clin Lab Investig. 2020;80:441–7. https://doi.org/10.1080/00365513.2020.1768587.

  27. Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta. 2020;510:475–82. https://doi.org/10.1016/j.cca.2020.08.019.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Xie Y, Wang Z, Liao H, Marley G, Wu D, Tang W. Epidemiologic, clinical, and laboratory findings of the COVID-19 in the current pandemic: systematic review and meta-analysis. BMC Infect Dis. 2020;20:640. https://doi.org/10.1186/s12879-020-05371-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Bauman WA, La Fountaine MF, Spungen AM. Age-related prevalence of low testosterone in men with spinal cord injury. J Spinal Cord Med. 2014;37:32–39.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Barbonetti A, Vassallo MRC, Felzani G, Francavilla S, Francavilla F. Association between 25(OH)-vitamin D and testosterone levels: evidence from men with chronic spinal cord injury. J Spinal Cord Med. 2016;39:246–52.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Stopsack KH, Mucci LA, Antonarakis ES, Nelson PS, Kantoff PW. TMPRSS2 and COVID-19: serendipity or opportunity for intervention? Cancer Discov. 2020;10:779–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Calvo E, Corbacho-Alonso N, Sastre-Oliva T, Nuñez E, Baena-Galan P, Hernandez-Fernandez G, et al. Why Does COVID-19 affect patients with spinal cord injury milder? a case-control study: results from two observational cohorts. J Pers Med. 2020;10:182.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Messner CB, Demichev V, Wendisch D, Michalick L, White M, Freiwald A, et al. Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection. Cell Syst. 2020;11:11–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors sincerely thank the participants and their families. The authors also thank the COVID-19 management team, Zoram Medical College, Falkawn, Mizoram, India for providing overall administrative, technical and material support.

Author information

Authors and Affiliations

Authors

Contributions

CZ and ARC conceived and designed the study, played an important role in interpreting the results, and drafted and revised the manuscript. VH, JCV, and LS designed the study, acquired data, and played an important role in interpreting the results along with drafting the manuscript. CZ was also additionally involved in acquiring data. ARC revised the different versions of the draft manuscript and finalized the final version which was approved by all the authors. All the authors agree to be accountable for all aspects of the work. ARC confirms that she had full access to the data in the study and takes final responsibility for submitting the article for publication.

Corresponding author

Correspondence to Asem Rangita Chanu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

All procedures involving human participants were in accordance with the Declaration of Helsinki 1964 as revised in 2013 and its later amendments or comparable ethical standards. The Institutional Ethics Committee, Zoram Medical College, Falkawn, Mizoram, India approved the retrospective study (No. F.20016/1/18-ZMC/IEC/63).

Informed consent

The Institutional Ethics Committee waived the requirement for informed written consent due to the retrospective nature of the study.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zonunsanga, C., Hruaii, V., Vanlalsanga, J.C. et al. Clinical profile of COVID-19 infection among persons with spinal cord injury: a case series. Spinal Cord Ser Cases 9, 34 (2023). https://doi.org/10.1038/s41394-023-00592-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41394-023-00592-4

Search

Quick links